BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2014
View Archived Issues
Gut-targeted anti-TNF polyclonal antibody granted U.S orphan status for pediatric ulcerative colitis
Read More
Milestone Pharmaceuticals reports phase I data for MSP-2017
Read More
In vivo data show strong antitumor activity of the novel FGFR/VEGR inhibitor ODM-203
Read More
Endo acquires rights to Natesto testosterone nasal gel
Read More
OncoSec and UCSF collaborate to study pembrolizumab and ImmunoPulse in metastatic melanoma
Read More
Orgenesis receives grant for autologous hepatocyte-derived therapy for type 1 diabetes
Read More
Low-affinity NMDA channel blockers could be useful for Rett syndrome
Read More
Adiponectin-like peptide agonist useful for hepatic fibrosis
Read More
Amarantus reports preclinical data on MANF in a model of retinitis pigmentosa
Read More
Antiviral drug discovery companies Cocrystal Pharma and RFS Pharma complete merger
Read More
Phase I results demonstrate safety of CTO plus bevacizumab in patients with malignant glioma
Read More
Researchers present in vivo data for a novel highly selective aldosterone synthase inhibitor
Read More
Antibe Therapeutics discloses HS-releasing prostaglandin inhibitor for acute pain
Read More
Interferon gene signature suppression with sifalimumab and anifrolumab in patients with SLE
Read More
Nordic Nanovector and Affibody collaborate on radioimmunotherapies for multiple myeloma
Read More
FDA requests additional data on daclatasvir in combination with other HCV drugs
Read More
Vargatef approved in E.U. for second-line treatment of NSCLC
Read More
Brd4 inhibitors prepared and tested at Gilead Sciences
Read More
Janssen patent describes compounds for HBV infection
Read More
Boehringer Ingelheim reports development of ACC2 inhibitors
Read More
Merck & Co. divulges HIV integrase inhibitors
Read More
FDA issues complete response letter for Avanir's AVP-825 for migraine
Read More
Spanish researchers describe HDAC inhibitors
Read More
Intra-Cellular Therapies initiates phase III trial of ITI-007 in schizophrenia
Read More
Regen BioPharma acquires cancer stem cell intellectual property from University of Toronto
Read More